glp-1 agonists ozempic Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns GLP-1 Agonists: A Comprehensive Overview

Tirzepatide versus Semaglutide once Weekly in patients with type 2 diabetes

If you have a seizure while taking CONTRAVE, stop taking CONTRAVE and call your healthcare provider right away

In obese and metabolic-risk populations, higher doses have produced weight loss of up to 15% of baseline body weight

Potential selection criteria might include: Adolescents with BMI 95th percentile for age and sex History of unsuccessful comprehensive lifestyle interventions Presence of obesity-related comorbidities Absence of contraindications (eating disorders, severe mental illness) Adequate family support and resources for monitoring Informed consent and assent processes completed Monitoring and Follow-up Comprehensive monitoring protocols are essential for safe and effective use of GLP-1 RAs in adolescents